tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

RLFTF Stock Latest News

MindMaze Wins Baader Bank Coverage With Buy Rating, Boosting Market Visibility
Company AnnouncementsMindMaze Wins Baader Bank Coverage With Buy Rating, Boosting Market Visibility
1d ago
MindMaze Names New CEO to Drive U.S. Expansion and Scale AI Neurotherapies
PremiumCompany Announcements
MindMaze Names New CEO to Drive U.S. Expansion and Scale AI Neurotherapies
8d ago
MindMaze maps post-listing push to scale digital neurotherapies in U.S. and Europe
PremiumCompany Announcements
MindMaze maps post-listing push to scale digital neurotherapies in U.S. and Europe
17d ago
MindMaze Sets Global Reimbursement Framework to Scale AI-Powered Neurorehabilitation
PremiumCompany Announcements
MindMaze Sets Global Reimbursement Framework to Scale AI-Powered Neurorehabilitation
3M ago
Relief Therapeutics and NeuroX Merge to Form MindMaze Therapeutics
PremiumCompany Announcements
Relief Therapeutics and NeuroX Merge to Form MindMaze Therapeutics
3M ago
Relief Therapeutics and NeuroX Announce Strategic Business Combination
PremiumCompany AnnouncementsRelief Therapeutics and NeuroX Announce Strategic Business Combination
4M ago
Relief Therapeutics to Merge with NeuroX, Forming MindMaze Therapeutics
Premium
Company Announcements
Relief Therapeutics to Merge with NeuroX, Forming MindMaze Therapeutics
4M ago
Relief Therapeutics Reports Positive Bioequivalence Study Results for PKU Treatment
Premium
Company Announcements
Relief Therapeutics Reports Positive Bioequivalence Study Results for PKU Treatment
5M ago
Relief Therapeutics Plans Strategic Merger with NeuroX Group
PremiumCompany Announcements
Relief Therapeutics Plans Strategic Merger with NeuroX Group
5M ago
Relief Therapeutics and NeuroX Merge to Form AI-Driven Health Tech Leader
PremiumCompany Announcements
Relief Therapeutics and NeuroX Merge to Form AI-Driven Health Tech Leader
5M ago
Relief Therapeutics Advances Pipeline and Explores AI-driven Expansion
PremiumCompany Announcements
Relief Therapeutics Advances Pipeline and Explores AI-driven Expansion
7M ago
Relief Therapeutics Advances 2025 Half-Year Report Publication
PremiumCompany Announcements
Relief Therapeutics Advances 2025 Half-Year Report Publication
7M ago
Relief Therapeutics to Merge with NeuroX, Expanding AI-Driven Health Tech Platform
PremiumCompany AnnouncementsRelief Therapeutics to Merge with NeuroX, Expanding AI-Driven Health Tech Platform
8M ago
Relief Therapeutics’ RLF-TD011 Faces Setback with FDA Decision
Premium
Company Announcements
Relief Therapeutics’ RLF-TD011 Faces Setback with FDA Decision
9M ago
Relief Therapeutics Secures Strong Shareholder Support at AGM
Premium
Company Announcements
Relief Therapeutics Secures Strong Shareholder Support at AGM
9M ago
Relief Therapeutics Secures FDA Rare Pediatric Disease Designation for RLF-TD011
PremiumCompany Announcements
Relief Therapeutics Secures FDA Rare Pediatric Disease Designation for RLF-TD011
10M ago
Relief Therapeutics Announces 2025 AGM Agenda
PremiumCompany Announcements
Relief Therapeutics Announces 2025 AGM Agenda
10M ago
Relief Therapeutics Strengthens Financial Position and Advances Pipeline in 2024
PremiumCompany Announcements
Relief Therapeutics Strengthens Financial Position and Advances Pipeline in 2024
11M ago
Relief announces results of annual general meeting
PremiumThe Fly
Relief announces results of annual general meeting
2y ago
Acer Therapeutics, Relief announce FDA approval of Olpruva
PremiumThe FlyAcer Therapeutics, Relief announce FDA approval of Olpruva
3y ago
ACER

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >